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Nizar R AlWaqfi1*, Khaled S Ibrahim1, Yousef S Khader2 and Ahmad Abu Baker3Abstract
Background: Although temporary cardiac pacing is infrequently needed, temporary epicardial pacing wires are
routinely inserted after valve surgery. As they are associated with infrequent, but life threatening complications, and
the decreased need for postoperative pacing in a group of low risk patients; this study aims to identify the
predictors of temporary cardiac pacing after valve surgery.
Methods: A retrospective analysis of data collected prospectively on 400 consecutive valve surgery patients
between May 2002 and December 2012 was performed. Patients were grouped according to avoidance or insertion
of temporary pacing wires, and were further subdivided according to temporary cardiac pacing need. Multiple
logistic regression was used to determine the predictors of temporary cardiac pacing.
Results: 170 (42.5%) patients did not have insertion of temporary pacing wires and none of them needed
temporary pacing. 230 (57.5%) patients had insertion of temporary pacing wires and among these, only 55 (23.9%)
required temporary pacing who were compared with the remaining 175 (76.1%) patients in the main analysis. The
determinants of temporary cardiac pacing (adjusted odds ratios; 95% confidence interval) were as follows: increased
age (1.1; 1.1, 1.3, p = 0.002), New York Heart Association class III- IV (5.6; 1.6, 20.2, p = 0.008) , pulmonary artery
pressure ≥ 50 mmHg (22.0; 3.4, 142.7, p = 0.01), digoxin use (8.0; 1.3, 48.8, p = 0.024), multiple valve surgery (13.5;
1.5, 124.0, p = 0.021), aorta cross clamp time ≥ 60 minutes (7.8; 1.6, 37.2, p = 0.010), and valve annulus calcification
(7.9; 2.0, 31.7, p = 0.003).
Conclusion: Although limited by sample size, the present results suggest that routine use of temporary epicardial
pacing wires after valve surgery is only necessary for high risk patients. Preoperative identification and aggressive
management of predictors of temporary cardiac pacing and the possible modulation of intraoperative techniques
can decrease the need of temporary cardiac pacing. Prospective randomized controlled studies on a larger number
of patients are necessary to draw solid conclusions regarding the selective use of temporary epicardial pacing wires
in valve surgery.
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Starting 1960s, temporary epicardial pacing wires (PWs)
were routinely placed in all cardiac operations for thera-
peutic as well as diagnostic purposes [1,2]. They remain
in place anywhere from 24 hours to several days postop-
eratively and are used to maintain heart rate and rhythm
which are necessary to optimize haemodynamics [3] and
to suppress both atrial and ventricular tachyarrhythmias* Correspondence: nizarwaqfi@hotmail.com
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unless otherwise stated.[4]. The use of PWs is associated with increased re-
source utilization and infrequent, but life threatening
complications including hemorrhage, cardiac tamponade,
serious arrhythmias, and death. Also the retention of PWs
after cardiac surgery is not necessarily safe and may cause
serious complications [5-11].
The available data supports the use of PWs for selec-
ted cases after coronary artery bypass grafting (CABG)
surgery [5,6]. However, PWs are routinely inserted after
valve and congenital heart surgeries promoted by histo-
rical evidence of increased need for temporary cardiac
pacing (TCP) in such surgeries [12-14]. Recent limitedl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Ferrari et al. [15] reported TCP in 17% of their valve sur-
gery cases and Gupta et al. [16] in 30% of their congenital
heart surgery cases.
The aim of this study was to determine the predictors
of TCP in valve surgery with the potential to regulate
PWs insertion at our center.
Methods
Patients
This study is a retrospective review of the clinical, opera-
tive, and outcome data that is part of the prospectively
recorded cardiac intensive care unit (CICU) database. We
excluded patients who underwent redo valve surgery due
to their small number and patients with preoperative
high degree atrioventricular block (AVB). A total of
400 patients, 18 years or older underwent valve surgery at
King Abdullah University Hospital (KAUH), Jordan be-
tween May, 2002 and December, 2012, was included in
the analysis.
Lately, it is our clinical practice, and upon surgeon’s
discretion based on patient’s individual characteristics to
selectively insert PWs in valve surgery patients.
According to insertion or avoidance of PWs, two groups
of patients were identified: group 1; did not have PWs
inserted and never needed to be paced and group 2; had
PWs inserted. Group 2 was subdivided into patients who
needed TCP and those who did not need TCP. This study
was approved by the ethical committee at KAUH.
Variables
The need for postoperative TCP (if patients were paced
at the time of chest closure or at any time before hos-
pital discharge) was the outcome variable of interest. We
identified the demographic, clinical, preoperative (inclu-
ding drugs directly affecting the conduction system), and
intraoperative variables (including type of valve surgery)
as potential predictors of TCP (Table 1). Preoperative ar-
rhythmias were defined as atrial fibrillation (AF), low
grade AVB, or a bundle branch block diagnosed by elec-
trocardiogram (ECG). Type of valve surgery was sub-
divided into; mitral valve, aortic valve, multiple valve
(double or triple), and valve with CABG surgeries. There
were no cases of only-tricuspid valve surgery, but part of
a combined procedure.
Operative technique
All patients had median sternotomy. In mitral valve
surgery, cardiopulmonary bypass (CPB) was established
between the ascending aorta and bicaval venous cannula-
tion. Mitral valve was approached through a conventional
left lateral atriotomy. Perfusion was maintained at 2.0 to
2.4 L/min/m2, and systemic perfusion pressure was kept
at 60 - 80 mmHg. Myocardial protection was achievedby hypokalemic cold crystalloid antegrade cardioplegia
(10-12 ml/kg) at a rate of 200 – 250 ml/min, in addition
to 300 ml repeated every 10 to 15 minutes. In aortic valve
surgery an extra half dose of cardioplegia was given dir-
ectly into the coronary ostia. Patients were cooled down
to 28-32°C. Cold saline was used to cool surface of the
heart. Valve annulus debridement of calcium was done
usually in a blunt fashion. Patients were evaluated on an
individual basis to determine if TCP is required. Patients
who received PWs had ventricular wires on the anterior
surface of the right ventricle. Atrial wires were additionally
placed when AVB occurred after separation from CPB.
After surgery all patients were transferred to CICU on
mechanical ventilation. Continuous ECG monitoring was
used in all patients. 12-lead ECG was performed for all pa-
tients upon CICU admission and daily till discharge from
hospital.
Statistical analysis
Statistical analysis was carried out using Statistical Pack-
age for Social Sciences (SPSS, version 15). Descriptive sta-
tistics were obtained, such as mean values for continuous
variables and proportions for categorical variables. The re-
lationships between pacing and possible predictors were
analyzed using Chi square test. Multiple logistic regres-
sion was used to determine the predictors of pacing in
the multivariate analysis. Only factors that were shown
to be significant predictors remained in the final regres-
sion model. A P-value ≤ 0.05 was considered statistically
significant.
Results
A total of 400 consecutive patients underwent valve sur-
gery with ages ranging from 18 to 80 years with mean
age (standard deviation- SD) of 51.81 (13.71) years.
Group 1 consisted of 170 (42.5%) patients with mean
age (SD) of 44.25 (12.85) years. No patient in group1 re-
quired pacing by any means nor suffered any complica-
tion attributed to avoidance of PWs. Group 2 consisted
of 230 (57.5%) patients with mean age (SD) of 57.39
(11.49) years. Table 1 shows the characteristics of both
groups with p-values. Among patients in group 2, only
55 (23.9%) needed TCP (mean age (SD) = 62.27 (10.87)
years) and were compared with the remaining 175 (76.1%)
patients (mean age (SD) = 55.86 (11.27) years) who did
not need TCP. 12-lead ECG was used to diagnose conduc-
tion disturbances. The primary reasons for pacing in-
cluded AVB of any degree in 25 (45.5%) patients, nodal or
junctional rhythms in 8 (14.6%) patients, low cardiac out-
put in 13 (23.6%) patients, sinus bradycardia in 5 (9.1%)
patients, and asystole in 4 (7.2%) patients. In no case were
PWs used for diagnostic purposes, rapid atrial pacing, or
left ventricular pacing. PWs were left in place for a mini-
mum of 3 days. The mean (SD) duration of pacing was
Table 1 Characteristics of total patients and by group
according to demographic, preoperative, and
intraoperative dataa
Variable Total Group 1 Group 2 p-value
(n = 400) (n = 170) (n = 230)
Age (year) < 0.005
< 40 78 (19.5) 62 (79.5) 16 (20.5)
40 – 59 187 (46.8) 88 (47.1) 99 (52.9)
≥ 60 135 (33.7) 20 (14.8) 115 (85.2)
Sex 0.141
Female 177 (44.3) 68 (38.4) 109 (61.6)
Male 223 (55.7) 102 (45.7) 121 (54.3)
Renal failure
(Creatinine≥ 1.5 mg/dl)
29 (7.3) 8 (27.6) 21 (72.4) 0.092
Diabetes mellitus 80 (20) 19 (23.7) 61 (76.3) < 0.005
COPD 49 (12.3) 29 (59.2) 20 (40.8) 0.012
History of arrhythmia 43 (10.8) 3 (7) 40 (93) < 0.005
NYHA Class 0.027
I – II 280 (70) 129 (46.1) 151 (53.9)




> 35 259 (64.5) 123 (47.5) 136 (52.5)
≤ 35 141 (35.5) 47 (33.3) 94 (66.7)
PAP (mmHg) 0.043
< 50 360 (90) 159 (44.2) 201 (55.8)
≥ 50 40 (10) 11 (27.5) 29 (72.5)
Preoperative medications < 0.005
Beta blockers 107 (26.8) 45 (42.1) 62 (57.9)
Digoxin 42 (10.5) 19 (55.2) 23 (54.8)
Amiodarone 18 (4.5) 2 (11.1) 16 (88.9)
Left atrium diameter (mm) 0.876
< 5.2 347 (86.7) 148 (42.7) 199 (57.3)
≥ 5.2 53 (13.3) 22 (41.5) 31 (58.5)
Type of surgery < 0.005
Mitral valve 140 (35) 80 (57.1) 60 (42.9)
Aortic valve 129(32.3) 57 (44.2) 72 (55.8)
Multiple valve 73 (18.2) 21 (28.8) 52 (71.2)
Valve with coronary
artery bypass
58 (14.5) 12 (20.7) 46 (79.3)




< 100 317 (79.3) 157 (49.5) 160 (50.5)
≥ 100 83 (20.7) 13 (15.7) 70 (84.3)
Table 1 Characteristics of total patients and by group
according to demographic, preoperative, and
intraoperative dataa (Continued)
Aorta cross clamp time
(minute)
< 0.005
< 60 318 (79.5) 160 (50.3) 158 (49.7)
≥ 60 82 (20.5) 10 (12.2) 72 (87.8)
Intraoperative bradycardia 101 (25.3) 46 (45.5) 55 (54.5) 0.474
a Data are given as no. (%).
COPD = chronic obstructive pulmonary disease; NYHA = New York Heart
Association; PAP = pulmonary artery pressure; PW = temporary epicardial
pacing wires.
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(9.1%) of the 55 patients who needed TCP, had implant-
ation of permanent pacemaker, accounting for 1.25% of
the cohort analyzed. The average time from surgery to im-
plantation of permanent pacemaker was 65.33 hours.
Table 2 shows the univariate analysis of demographic,
clinical, and preoperative characteristics of patients in
group 2, in relation to TCP. The use of TCP differed sig-
nificantly according to patients’ age, diabetes mellitus,
left ventricular ejection fraction (EF), New York Heart
Association (NYHA) status, pulmonary artery pressure
(PAP), and being on amiodarone. Patients on beta bloc-
kers were significantly less likely to need TCP.
Table 3 shows the univariate analysis of intraoperative
variables in relation to TCP. When analyzed by type of
surgery; 10% of patients who underwent mitral valve,
13.9% who underwent aortic valve, 34.8% who under-
went valve with CABG, and 44.2% who underwent mul-
tiple valve surgeries needed TCP.
Table 4 shows the predictors of TCP in the multivari-
ate analysis. Increased age by 1 year was associated with
increased odds of TCP by 10%. Those who underwent
multiple valve surgery were significantly more likely to
need TCP compared to patients who underwent single
valve surgery.
Discussion
Historically, PWs have been routinely used after cardiac
operations to optimize cardiac function and to suppress
both atrial and ventricular tachyarrhythmias [4]. How-
ever, their use is not innocuous and associated with in-
frequent but lethal complications. Insertion can prolong
the operative time and increase the risk of bleeding.
Their extended use can result in failure of sensing or
capturing [17]. During removal, patients are at risk of
ventricular arrhythmias [18] and to a lesser extent bleed-
ing due to injury of nearby structures [19-21]. Also re-
tention of PWs may be complicated by deep seated
infections or migration to different structures in the
chest [7-9,22,23].
Table 2 Univariate analysis (group 2) for use of






< 40 13 (81.3) 3 (18.8)
40–59 84 (84.8) 15 (15.20)
≥ 60 78 (67.8) 37 (32.2)
Sex
Female 79 (72.5) 30 (27.5) 0.223
Male 96 (79.3) 25 (20.7)
Renal failure (creatinine > 1.5 mg/dl) 0.991
No 159 (76.1) 50 (23.9)
Yes 16 (76.2) 5 (23.8)
Diabetes mellitus 0.001
No 119 (70.4) 50 (29.6)
Yes 56 (91.8) 5 (8.2)
COPD 0.504
No 161 (76.7) 49 (23.3)
Yes 14 (70.0) 6 (30.0)
History of arrhythmia 0.818
No 144 (75.8) 46 (24.2)
Yes 31 (77.5) 9 (22.5)
NYHA class 0.000
I-II 136 (90.1) 15 (9.9)
III-IV 39 (49.4) 40 (50.6)
Left Ventricle ejection fraction (%) 0.001
> 35 114 (83.8) 22 (16.2)
≤ 35 61 (64.9) 33 (35.1)
PAP (mmHg) 0.000
< 50 171 (85.1) 30 (14.9)
≥ 50 4 (13.8) 25 (86.2)
Left atrium diameter (mm) 0.104
< 5.2 155 (77.9) 44 (22.1)
≥ 5.2 20 (64.5) 11 (35.5)
Beta blockers 0.002
No 119 (70.8) 49 (29.2)
Yes 56 (90.3) 6 (9.70)
Digoxin 0.440
No 159 (76.8) 48 (23.2)
Yes 16 (69.6) 7 (30.4)
Amiodarone 0.011
No 167 (78.0) 47 (22.0)
Yes 8 (50.0) 8 (50.0)
aData are given as no. (%).
COPD = chronic obstructive pulmonary disease; NYHA = New York Heart
Association; PAP =pulmonary artery pressure.
Table 3 Univariate analysis (group 2) for use of





Type of surgery 0.000
Mitral valve 54 (90.0) 6 (10.0)
Aortic valve 62 (86.1) 10 (13.9)
Multiple valve 29 (55.8) 23 (44.2)
Valve with coronary artery bypass 30 (65.2) 16 (34.8)
Annulus Calcification 0.000
No 154 (87.0) 23 (13.0)
Yes 21 (39.6) 32 (60.4)
Cardiopulmonary bypass time (minute) 0.000
< 100 140 (87.5) 20 (12.5)
≥ 100 35 (50.0) 35 (50.0)
Aorta cross clamp time (minute) 0.000
< 60 143 (90.5) 15 (9.5)
≥ 60 32 (44.4) 40 (55.6)
Bradycardia 0.003
No 125 (71.4) 50 (28.6)
Yes 50 (90.9) 5 (9.1)
aData are given as no. (%).
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CABG surgery, being on-pump or a beating heart, has
been well studied and many centers turned to limit their
use [5,6,24]. We already comply with these policies. In
valvular and pediatric surgeries there is a historical evi-







Age 1.1 (1.1, 1.3) 0.002
NYHA class (III- IV) 5.6 (1.6, 20.2) 0.008
PAP≥ 50 mmHg 22.0 (3.4, 142.7) 0.001
Preoperative digoxin use 8.0 (1.3, 48.8) 0.024
Type of surgery
Mitral valve 1.0
Aortic valve 2.2 (0.3, 14.7) 0.431
Multiple valve 13.5 (1.5, 124.0) 0.021
Valve with coronary artery
bypass
3.6 (0.4, 30.7) 0.242
Aorta cross clamp time≥
60 min
7.8 (1.6, 37.2) 0.010
Valve annulus calcification 7.9 (2.0, 31.7) 0.003
NYHA = New York Heart Association; PAP = pulmonary artery pressure.
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old and may not reflect modern surgical techniques and
practice. Recent few reports studied the rate and the
predictors of TCP after valvular and pediatric cardiac
surgeries [15,16,25]. At our center, to avoid the above
mentioned complications and in accordance with the
published literature, and it is upon surgeon’s discretion
to safely select patients, we limited the insertion of PWs
in valve surgery (usually based on; young age with min-
imal comorbidities, uncomplicated single valve surgery,
not involving extensive decalcification, and after separ-
ation from CPB in sinus rhythm, and hemodynamically
stable on minimal support, including recently, patients
in sinus bradycardia who responds to minimal doses of
beta-adrenergic drugs) (Table 1).
The need for TCP was mainly based on the presence
of a mechanical injury to the conduction system caused
by operative procedures in close physical proximity to
the atrioventricular node or the His bundle, or an is-
chemic injury to the conduction system resulting during
cardioplegic arrest, especially if associated with extensive
coronary artery disease. Both mechanisms may evoke
preexisting conduction defects or generate new ones.
In our study, only 23.9% of valve surgery patients with
PWs insertion needed TCP which led us to reevaluate
the use of PWs and to attempt to identify a subpopula-
tion of valve patients for whom PWs are appropriate.
In the current series, patients who had PWs inserted
were almost 10 years older than those who did not, and
those more than 60 years old were, by both univariate
and multivariate analysis, more likely to be paced.
Gender was not a predictor of TCP. This is consistent
with other peer reviews [15,26].
Data in the literature regarding the significance of chro-
nic comorbidities such as chronic renal failure, chronic
obstructive pulmonary disease, diabetes mellitus and pre-
operative arrhythmias as predictors of postoperative pa-
cing are conflicting [14,15,27]. In our study none of the
above mentioned comorbidities were significantly associ-
ated with the need for TCP in the multivariate analysis.
Advanced NYHA class was a predictor of TCP in both
univariate and multivariate analysis. Pacing was used in
patients with advanced NYHA class to improve cardiac
output after separation from CPB to achieve hemody-
namic stability. Also, most of them had severe left ven-
tricular dysfunction with increased risk of developing
various conduction disturbances [28]. This finding was
supported by Gordon et al. [29]. On the contrary, ad-
vanced NYHA status was not a predictor of TCP by
Ferrari et al. [15].
Increased PAP was an independent predictor of TCP
by both univariate and multivariate analysis. Limongelli,
et al. [30] reported pulmonary hypertension a risk factor
for postoperative AVB following aortic valve surgery, asit acts on the right ventricular dimensions and shape,
and interventricular septal thickness imposing progres-
sive mechanical stretch that could affect the conduction
system by altering the electrophysiological properties of
its fibers.
Preoperative use of digoxin and beta-blockers are pos-
tulated as predictors of postoperative conduction dis-
turbance [14,31], especially of those with the block nature.
In a recent study on patients after mitral valve surgery by
Berdjas et al. [14], both digoxin and beta blockers, were
found to significantly lower the risk of conduction distur-
bances. In our study, only digoxin was a predictor of TCP.
Digoxin’s primary mechanism of action is to increase the
force of myocardial contractility in failing hearts by in-
creasing the intracellular calcium concentration. However,
its vagomimetic effect decreases sinoatrial and atrioven-
tricular conduction and prolongs atrioventricular node re-
fractory period, thus increasing the need for TCP [32].
Also digoxin has, even at therapeutic levels, an arrhyth-
mogenic effect on ischemic hearts [33], which may include
periods of prolonged crossclamping time.
Type of surgical procedure was a determinant of TCP.
Patients who had multiple valve surgery and/or debride-
ment of heavy annular calcification at the atrioventricu-
lar sinus area (the posterior commissure of the anterior
mitral leaflet, the commissure between right- and non-
coronary cusps of the aortic valve, and the septal leaflet
of the tricuspid valve) were at an increased risk of phys-
ical injury to the atrioventricular node and conduction
system and were significantly more likely to need TCP
after separation from CPB. Although the need for pacing
in combined valve and CABG surgery was more than in
isolated single valve surgery, this difference did not reach
statistical significance. This might be due to small sample
size of this subgroup. In such patients it may be difficult
to assure adequate and uniform delivery of the cardio-
plegic solution to protect the myocardium leading to new
or further exacerbating existing conduction disturbances.
These results coincide with other peer reviews [29,34].
Aortic crossclamp time more than 60 minutes, by both
univariate and multivariate analysis, was a predictor of
TCP. This is consistent with other peer reviews [35]. The
occurrence of ischemic injury to the conduction system
and the development of myocardial edema following pro-
longed periods of crossclamping might explain these
findings.
In the interpretation of the study findings, we need to
consider that this study is a retrospective analysis with a
relatively limited number of patients done over a long
time; however patients were followed prospectively du-
ring their hospitalization. Although a team of different
surgeons performed the operations with different thre-
shold for postoperative PWs insertion and pacing, all
the patients were treated at a single center, and the
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ing the study.
Conclusion
Although limited by sample size, the present results sug-
gest that routine use of PWs after valve surgery is neces-
sary for high risk patients. Predictive factors of TCP after
valve surgery were increased age, NYHA class (III-IV),
PAP ≥ 50 mmHg, digoxin use, complex surgical proce-
dures (i.e. multiple valve surgery), heavy annular calcifi-
cation, and crossclamp time ≥ 60 min. Better patients
selection, in addition to optimizing the medical condi-
tion through aggressive treatment of heart failure and
pulmonary hypertension, shortening the cross clamping
and CPB times, and careful debridement of calcified valve
annulus, may lower the need for postoperative pacing in
our practice. Prospective randomized well controlled stud-
ies on a larger number of patients, including quantitative
assessment of valve annular calcium load and distribution,
are necessary to draw solid conclusions on safely selected
patients who do not require postoperative PWs insertion.
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